心肌炎
炎症体
炎症
体内
MAPK/ERK通路
药理学
医学
心功能曲线
细胞生物学
信号转导
化学
免疫学
生物
内科学
心力衰竭
生物技术
作者
Youqiong Zhuo,Jia He,Qinqin Wang,Yuntian Xiao,Xiaoyun Xie,Lina Liu,Shilin Yang,Jingjing Li,Renyikun Yuan,Hongwei Gao
标识
DOI:10.3389/fphar.2025.1589298
摘要
Background Myocarditis is an inflammation of the myocardium caused by a variety of reasons, with myocardial cell necrosis and interstitial inflammatory cell infiltration as the main manifestations. Pedunculoside (PE) plays a protective role in inflammatory diseases; however, it’s effect and mechanism on myocarditis remains unexplored. Methods In this study, we evaluated the cardioprotective effects of PE in vivo and in vitro using the LPS + ATP-induced cardiomyocyte injury model and the LPS-induced rat myocarditis model, and elucidated its potential mechanism. Results We found that PE demonstrated inhibition of H9c2 cell death and decreased ROS, Ca 2+ levels, and MMP loss induced by LPS + ATP. Moreover, PE improved cardiac function in LPS-induced myocarditis rats. Mechanistically, PE suppressed the activation of the NLRP3 inflammasome, PIP2, and MAPK signaling pathways, which are associated with P2X7R. Additionally, PE interfered with and attenuated the interaction between P2X7R and PIP2, displaying strong docking activity with P2X7R. Conclusion Taken together, PE exhibited significant anti-myocarditis activity by interacting with P2X7R and inhibiting the NLRP3, PIP2, and MAPK pathways, highlighting its potential as a therapeutic agent for clinical myocarditis treatment.
科研通智能强力驱动
Strongly Powered by AbleSci AI